Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.133NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.466NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.489NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.363NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.95NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.531NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.200NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.299NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.55NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.149NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.300NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.179NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.125NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
G.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.438NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.178NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.208NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.197NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.491NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.8 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.190NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.552NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AF.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.89NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
M.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.333NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.429NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.463NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
U.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.373NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.80NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.433NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.36.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AN.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.221.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.242NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.449NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.152NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used